Abstract:

Objective: We evaluated the distribution, use of antivenom, treatments applied during the follow-ups, and effects on the use of NLR and MPV antivenom in cases of snake bites and scorpion stings followed in the paediatric intensive care unit (PICU) and the effects of these cases on the length of stay in the intensive care unit and hospital. Materials and Methods: Demographic characteristics of the patients followed in the PICU and the severity of their clinical findings at admission, antivenom use after snake and scorpion bites were retrospectively examined from the clinical course in the hospital automation system and archived file records. Results: Of 38 patients who were followed up in the PICU for snake and scorpion bites, half were followed up for snake bites and half for scorpion bites. Antivenom treatment was applied according to the clinical stage. There was a positive correlation between antivenom-administered patients and NLR (p<0,05). When snake bites and scorpion stings were examined separately, there was a positive correlation between antivenom application and NLR in snake bites (p<0.05), but no correlation was found in scorpion stings (p>0.05). Conclusion: Consequently, antivenom therapy is the main treatment for snake bites and scorpion stings. We think that the NLR value will be significant in deciding to apply antivenom to patients, especially in snake bites. In addition, those with high NLR values need to be closely observed in terms of compartment development.

Keywords: